FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teumer, J.
Right arrow Articles by Green, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teumer, J.
Right arrow Articles by Green, H.

The FASEB Journal, Vol 4, 3245-3250, Copyright © 1990 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes

J Teumer, A Lindahl and H Green
Department of Cellular and Molecular Physiology, Harvard Medical School, Boston, Massachusetts 02115.

An established line of human epidermal keratinocytes was permanently transformed by transfection with plasmid vectors bearing the human growth hormone gene under the control of two different promoters. Suitable selection permitted the isolation of clones secreting abundant growth hormone in culture. When such cultures were grafted to athymic mice, human growth hormone could be detected in the blood of the mice at concentrations in the physiological range for more than 4 weeks. Retrograde transfer from epithelial cells should be studied further as a possible means of introducing exogenous gene products into the circulation of humans.


This article has been cited by other articles:


Home page
 Stem CellsHome page
S. Papini, D. Cecchetti, D. Campani, W. Fitzgerald, J. C. Grivel, S. Chen, L. Margolis, and R. P. Revoltella
Isolation and Clonal Analysis of Human Epidermal Keratinocyte Stem Cells in Long-Term Culture
Stem Cells, July 1, 2003; 21(4): 481 - 494.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. LARCHER, M. DEL RIO, F. SERRANO, J. C. SEGOVIA, A. RAMIREZ, A. MEANA, A. PAGE, J. L. ABAD, M. A. GONZALEZ, J. BUEREN, et al.
A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts
FASEB J, July 1, 2001; 15(9): 1529 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. Wang, S. Zinkel, K. Polonsky, and E. Fuchs
Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy
PNAS, January 7, 1997; 94(1): 219 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J Cheng, K Turksen, Q C Yu, H Schreiber, M Teng, and E Fuchs
Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
Genes & Dev., August 1, 1992; 6(8): 1444 - 1456.
[Abstract] [PDF]

Home page
 ScienceHome page
J Dhawan, L. Pan, G. Pavlath, M. Travis, A. Lanctot, and H. Blau
Systemic delivery of human growth hormone by injection of genetically engineered myoblasts
Science, December 6, 1991; 254(5037): 1509 - 1512.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The Federation of American Societies for Experimental Biology.